In vitro natural killer activity against progressive and regressive variants of a rat colon adenocarcinoma. Effect of treatments with anti-asialo GM1 plus complement

Immunobiology. 1987 Sep;175(3):202-13. doi: 10.1016/S0171-2985(87)80029-3.

Abstract

In a previous work, a cell line (DHD/K12) was established from a colon adenocarcinoma induced in a BDIX rat by 1,2-dimethylhydrazine. From this line, two cloned sublines, PROb and REGb, were then isolated. When subcutaneously inoculated into syngeneic rats, PROb cells yield progressive tumors, whereas REGb cells yield tumors which regress. In this study, in a 16-h 51Cr release assay, natural cytotoxicity mediated by BDIX splenic nonadherent lymphoid cells (NK cells) was shown to be much higher against REGb cells than against PROb cells. Whatever the target cells, NK cytotoxicity was always higher when the effector cells were obtained from males rather than from females. Treatment of BDIX splenic lymphocytes by anti-asGM1 serum plus complement revealed that both anti-asGM1 sensitive and non-sensitive NK cells exist. The activity of anti-asGM1 non-sensitive NK cells appeared to be minor and to be detected only when the level of cytotoxicity before treatment was sufficiently high. The difference between PROb and REGb tumor growth appears to be linked, at least in part, to a higher sensitivity of REGb cells to NK cells and especially to anti-asGM1-sensitive NK cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / immunology*
  • Animals
  • Antibodies / immunology
  • Clone Cells / immunology
  • Colonic Neoplasms / immunology*
  • Complement System Proteins / immunology
  • Cytotoxicity, Immunologic
  • G(M1) Ganglioside*
  • Glycosphingolipids / immunology*
  • Killer Cells, Natural / immunology*
  • Rats

Substances

  • Antibodies
  • Glycosphingolipids
  • G(M1) Ganglioside
  • asialo GM1 ganglioside
  • Complement System Proteins